Evidence map›Paper›PMID 40072485›Full record

ArticleJournal of medical Internet research2025

Two-Year Hypertension Incidence Risk Prediction in Populations in the Desert Regions of Northwest China: Prospective Cohort Study.

Yinlin Cheng, Kuiying Gu, Weidong Ji, Zhensheng Hu, Yining Yang, Yi Zhou

Abstract read
In one paragraph

Article in Journal of medical Internet research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yinlin Cheng *Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.ORCID https://orcid.org/0000-0002-6253-9664
Kuiying Gu *School of Public Health, Soochow University, Suzhou, China.ORCID https://orcid.org/0009-0009-9536-2349
Weidong JiZhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.ORCID https://orcid.org/0009-0000-1168-6341
Zhensheng HuZhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.ORCID https://orcid.org/0009-0009-7255-1518
Yining YangPeople's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China.ORCID https://orcid.org/0000-0003-0003-2208
Yi ZhouZhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.ORCID https://orcid.org/0000-0002-4774-2234

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHypertension is a major global health issue and a significant modifiable risk factor for cardiovascular diseases, contributing to a substantial socioeconomic burden due to its high prevalence. In China, particularly among populations living near desert regions, hypertension is even more prevalent due to unique environmental and lifestyle conditions, exacerbating the disease burden in these areas, underscoring the urgent need for effective early detection and intervention strategies.

objectiveThis study aims to develop, calibrate, and prospectively validate a 2-year hypertension risk prediction model by using large-scale health examination data collected from populations residing in 4 regions surrounding the Taklamakan Desert of northwest China.

methodsWe retrospectively analyzed the health examination data of 1,038,170 adults (2019-2021) and prospectively validated our findings in a separate cohort of 961,519 adults (2021-2023). Data included demographics, lifestyle factors, physical examinations, and laboratory measurements. Feature selection was performed using light gradient-boosting machine-based recursive feature elimination with cross-validation and Least Absolute Shrinkage and Selection Operator, yielding 24 key predictors. Multiple machine learning (logistic regression, random forest, extreme gradient boosting, light gradient-boosting machine) and deep learning (Feature Tokenizer + Transformer, SAINT) models were trained with Bayesian hyperparameter optimization.

resultsOver a 2-year follow-up, 15.20% (157,766/1,038,170) of the participants in the retrospective cohort and 10.50% (101,077/961,519) in the prospective cohort developed hypertension. Among the models developed, the CatBoost model demonstrated the best performance, achieving area under the curve (AUC) values of 0.888 (95% CI 0.886-0.889) in the retrospective cohort and 0.803 (95% CI 0.801-0.804) in the prospective cohort. Calibration via isotonic regression improved the model's probability estimates, with Brier scores of 0.090 (95% CI 0.089-0.091) and 0.102 (95% CI 0.101-0.103) in the internal validation and prospective cohorts, respectively. Participants were ranked by the positive predictive value calculated using the calibrated model and stratified into 4 risk categories (low, medium, high, and very high), with the very high group exhibiting a 41.08% (5741/13,975) hypertension incidence over 2 years. Age, BMI, and socioeconomic factors were identified as significant predictors of hypertension.

conclusionsOur machine learning model effectively predicted the 2-year risk of hypertension, making it particularly suitable for preventive health care management in high-risk populations residing in the desert regions of China. Our model exhibited excellent predictive performance and has potential for clinical application. A web-based application was developed based on our predictive model, which further enhanced the accessibility for clinical and public health use, aiding in reducing the burden of hypertension through timely prevention strategies.

Indexed as

HypertensionAdultAgedChinaCohort StudiesDesert ClimateFemaleHumansIncidenceMachine LearningMaleMiddle AgedProspective StudiesRetrospective StudiesRisk AssessmentRisk Factorsclinical applicabilitydeep learningdeserthypertensionmachine learningprevention

Identifiers

PMID40072485
PMCPMC11947627

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.